Skip to main content
Premium Trial:

Request an Annual Quote

ISB Renews Prostate Cancer Collaboration with Lynx

NEW YORK, May 14 - Seattle's Institute for Systems Biology has renewed a collaboration with Lynx Therapeutics to study gene expression in prostate cancer, the company said today.

 

Lynx will apply its core "Massively Parallel Signature Sequencing" technology to identify genes that are differentially expressed in this cancer, and ISB will contribute other data.

 

The initial collaboration, begun about one year ago, led to the discovery of "numerous potential prostate cancer-specific genes," which the partners are preparing to publish.

 

"Because of its ability in detecting transcripts expressed at extremely low levels, MPSS technology enabled us to monitor global changes in gene expression and to start building pathways and networks perturbed in prostate cancer cells," said Biaoyang Lin, a senior scientist and project leader at ISB, in a statement.

 

This new agreement will include additional MPSS analysis of prostate cancer patient biopsy samples.

 

Lynx will be paid fees for the services it performs under the agreement, but the parties did not disclose the amount of these fees. The ISB garned funding for the continuation of the study through an award from prostate cancer research nonprofit CapCURE, Lynx said.

 

Prostate cancer typically progresses from a localized androgen-dependent disease to a more dangerous metastatic form, but the biological details of this transformation are not well understood. The systems biology approach, according to Lynx, may provide new insights into the mechanisms of this disease.

The Scan

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.

Fragile X Syndrome Mutations Found With Comprehensive Testing Method

Researchers in Clinical Chemistry found fragile X syndrome expansions and other FMR1 mutations with ties to the intellectual disability condition using a long-range PCR and long-read sequencing approach.

Team Presents Strategy for Speedy Species Detection in Metagenomic Sequence Data

A computational approach presented in PLOS Computational Biology produced fewer false-positive species identifications in simulated and authentic metagenomic sequences.

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.